APO Research
Talk to an analyst

APO RESEARCH · REPORT

Probiotics for Middle-aged and Elderly

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Probiotics for Middle-aged and Elderly Market Outlook and Growth Opportunities 2026

5 July 2026203 pages

Choose your research edition.

Industry ResearchProbiotics for Middle-aged and Elderly Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Probiotics for Middle-aged and Elderly Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Probiotics for Middle-aged and Elderly Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Probiotics for Middle-aged and Elderly Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Probiotics for Middle-aged and Elderly Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Probiotics for Middle-aged and Elderly market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Probiotics for Middle-aged and Elderly is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Probiotics for Middle-aged and Elderly is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Probiotics for Middle-aged and Elderly is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Probiotics for Middle-aged and Elderly market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Probiotics for Middle-aged and Elderly market include DuPont(Danisco), Chr. Hansen, China-Biotics, Nestle, Danone, BioGaia, OMNi-BiOTiC, Glory Biotech and Ganeden, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Probiotics for Middle-aged and Elderly market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Probiotics for Middle-aged and Elderly and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Probiotics for Middle-aged and Elderly sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Probiotics for Middle-aged and Elderly market size, projected growth trends, production technologies, key applications, and end-use industries.

Probiotics for Middle-aged and Elderly Segment by Company

DuPont(Danisco)

Chr. Hansen

China-Biotics

Nestle

Danone

BioGaia

OMNi-BiOTiC

Glory Biotech

Ganeden

Morinaga Milk Industry

Sabinsa

Greentech

Bioriginal

Biosearch Life

UAS Laboratories

Synbiotech

Probiotics for Middle-aged and Elderly Segment by Type

Lactic Acid Bacteria

Bifidobacterium

Others

Probiotics for Middle-aged and Elderly Segment by Application

Supermarket

Online Retail

Others

Probiotics for Middle-aged and Elderly Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Probiotics for Middle-aged and Elderly status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Probiotics for Middle-aged and Elderly market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Probiotics for Middle-aged and Elderly significant trends, drivers, influence factors in global and regions.

6. To analyze Probiotics for Middle-aged and Elderly competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Probiotics for Middle-aged and Elderly market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Probiotics for Middle-aged and Elderly and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Probiotics for Middle-aged and Elderly.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Probiotics for Middle-aged and Elderly market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Probiotics for Middle-aged and Elderly industry.

Chapter 3: Detailed analysis of Probiotics for Middle-aged and Elderly manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Probiotics for Middle-aged and Elderly in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Probiotics for Middle-aged and Elderly in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Probiotics for Middle-aged and Elderly Industry Trends Table 2. Probiotics for Middle-aged and Elderly Industry Drivers Table 3. Probiotics for Middle-aged and Elderly Industry Opportunities and Challenges Table 4. Probiotics for Middle-aged and Elderly Industry Restraints Table 5. Global Probiotics for Middle-aged and Elderly Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Probiotics for Middle-aged and Elderly Revenue Share by Company (2021-2026) Table 7. Global Probiotics for Middle-aged and Elderly Sales Volume by Company (k units) & (2021-2026) Table 8. Global Probiotics for Middle-aged and Elderly Sales Volume Share by Company (2021-2026) Table 9. Global Probiotics for Middle-aged and Elderly Average Price (USD/unit) of Company (2021-2026) Table 10. Global Probiotics for Middle-aged and Elderly Company Ranking, (2024-2026) & (USD Million) Table 11. Global Probiotics for Middle-aged and Elderly Key Company Manufacturing Base & Headquarters Table 12. Global Probiotics for Middle-aged and Elderly Company, Product Type & Application Table 13. Global Probiotics for Middle-aged and Elderly Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Probiotics for Middle-aged and Elderly by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Lactic Acid Bacteria Table 18. Significant Companies of Bifidobacterium Table 19. Significant Companies of Others Table 20. Global Probiotics for Middle-aged and Elderly Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Probiotics for Middle-aged and Elderly Sales Volume by Type (2021-2026) & (k units) Table 22. Global Probiotics for Middle-aged and Elderly Sales Volume by Type (2027-2032) & (k units) Table 23. Global Probiotics for Middle-aged and Elderly Sales Volume Share by Type (2021-2026) Table 24. Global Probiotics for Middle-aged and Elderly Sales Volume Share by Type (2027-2032) Table 25. Global Probiotics for Middle-aged and Elderly Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Probiotics for Middle-aged and Elderly Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Probiotics for Middle-aged and Elderly Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Probiotics for Middle-aged and Elderly Sales Value Share by Type (2021-2026) Table 29. Global Probiotics for Middle-aged and Elderly Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Supermarket Table 31. Significant Companies of Online Retail Table 32. Significant Companies of Others Table 33. Global Probiotics for Middle-aged and Elderly Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Probiotics for Middle-aged and Elderly Sales Volume by Application (2021-2026) & (k units) Table 35. Global Probiotics for Middle-aged and Elderly Sales Volume by Application (2027-2032) & (k units) Table 36. Global Probiotics for Middle-aged and Elderly Sales Volume Share by Application (2021-2026) Table 37. Global Probiotics for Middle-aged and Elderly Sales Volume Share by Application (2027-2032) Table 38. Global Probiotics for Middle-aged and Elderly Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Probiotics for Middle-aged and Elderly Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Probiotics for Middle-aged and Elderly Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Probiotics for Middle-aged and Elderly Sales Value Share by Application (2021-2026) Table 42. Global Probiotics for Middle-aged and Elderly Sales Value Share by Application (2027-2032) Table 43. Global Probiotics for Middle-aged and Elderly Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Probiotics for Middle-aged and Elderly Sales by Region (2021-2026) & (k units) Table 45. Global Probiotics for Middle-aged and Elderly Sales Market Share by Region (2021-2026) Table 46. Global Probiotics for Middle-aged and Elderly Sales by Region (2027-2032) & (k units) Table 47. Global Probiotics for Middle-aged and Elderly Sales Market Share by Region (2027-2032) Table 48. Global Probiotics for Middle-aged and Elderly Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Probiotics for Middle-aged and Elderly Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Probiotics for Middle-aged and Elderly Sales Value Share by Region (2021-2026) Table 51. Global Probiotics for Middle-aged and Elderly Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Probiotics for Middle-aged and Elderly Sales Value Share by Region (2027-2032) Table 53. Global Probiotics for Middle-aged and Elderly Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Probiotics for Middle-aged and Elderly Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Probiotics for Middle-aged and Elderly Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Probiotics for Middle-aged and Elderly Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Probiotics for Middle-aged and Elderly Sales by Country (2021-2026) & (k units) Table 58. Global Probiotics for Middle-aged and Elderly Sales Market Share by Country (2021-2026) Table 59. Global Probiotics for Middle-aged and Elderly Sales by Country (2027-2032) & (k units) Table 60. Global Probiotics for Middle-aged and Elderly Sales Market Share by Country (2027-2032) Table 61. Global Probiotics for Middle-aged and Elderly Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Probiotics for Middle-aged and Elderly Sales Value Market Share by Country (2021-2026) Table 63. Global Probiotics for Middle-aged and Elderly Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Probiotics for Middle-aged and Elderly Sales Value Market Share by Country (2027-2032) Table 65. DuPont(Danisco) Company Information Table 66. DuPont(Danisco) Business Overview Table 67. DuPont(Danisco) Probiotics for Middle-aged and Elderly Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. DuPont(Danisco) Probiotics for Middle-aged and Elderly Product Portfolio Table 69. DuPont(Danisco) Recent Development Table 70. Chr. Hansen Company Information Table 71. Chr. Hansen Business Overview Table 72. Chr. Hansen Probiotics for Middle-aged and Elderly Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. Chr. Hansen Probiotics for Middle-aged and Elderly Product Portfolio Table 74. Chr. Hansen Recent Development Table 75. China-Biotics Company Information Table 76. China-Biotics Business Overview Table 77. China-Biotics Probiotics for Middle-aged and Elderly Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. China-Biotics Probiotics for Middle-aged and Elderly Product Portfolio Table 79. China-Biotics Recent Development Table 80. Nestle Company Information Table 81. Nestle Business Overview Table 82. Nestle Probiotics for Middle-aged and Elderly Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Nestle Probiotics for Middle-aged and Elderly Product Portfolio Table 84. Nestle Recent Development Table 85. Danone Company Information Table 86. Danone Business Overview Table 87. Danone Probiotics for Middle-aged and Elderly Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Danone Probiotics for Middle-aged and Elderly Product Portfolio Table 89. Danone Recent Development Table 90. BioGaia Company Information Table 91. BioGaia Business Overview Table 92. BioGaia Probiotics for Middle-aged and Elderly Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. BioGaia Probiotics for Middle-aged and Elderly Product Portfolio Table 94. BioGaia Recent Development Table 95. OMNi-BiOTiC Company Information Table 96. OMNi-BiOTiC Business Overview Table 97. OMNi-BiOTiC Probiotics for Middle-aged and Elderly Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. OMNi-BiOTiC Probiotics for Middle-aged and Elderly Product Portfolio Table 99. OMNi-BiOTiC Recent Development Table 100. Glory Biotech Company Information Table 101. Glory Biotech Business Overview Table 102. Glory Biotech Probiotics for Middle-aged and Elderly Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Glory Biotech Probiotics for Middle-aged and Elderly Product Portfolio Table 104. Glory Biotech Recent Development Table 105. Ganeden Company Information Table 106. Ganeden Business Overview Table 107. Ganeden Probiotics for Middle-aged and Elderly Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Ganeden Probiotics for Middle-aged and Elderly Product Portfolio Table 109. Ganeden Recent Development Table 110. Morinaga Milk Industry Company Information Table 111. Morinaga Milk Industry Business Overview Table 112. Morinaga Milk Industry Probiotics for Middle-aged and Elderly Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Morinaga Milk Industry Probiotics for Middle-aged and Elderly Product Portfolio Table 114. Morinaga Milk Industry Recent Development Table 115. Sabinsa Company Information Table 116. Sabinsa Business Overview Table 117. Sabinsa Probiotics for Middle-aged and Elderly Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Sabinsa Probiotics for Middle-aged and Elderly Product Portfolio Table 119. Sabinsa Recent Development Table 120. Greentech Company Information Table 121. Greentech Business Overview Table 122. Greentech Probiotics for Middle-aged and Elderly Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Greentech Probiotics for Middle-aged and Elderly Product Portfolio Table 124. Greentech Recent Development Table 125. Bioriginal Company Information Table 126. Bioriginal Business Overview Table 127. Bioriginal Probiotics for Middle-aged and Elderly Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Bioriginal Probiotics for Middle-aged and Elderly Product Portfolio Table 129. Bioriginal Recent Development Table 130. Biosearch Life Company Information Table 131. Biosearch Life Business Overview Table 132. Biosearch Life Probiotics for Middle-aged and Elderly Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Biosearch Life Probiotics for Middle-aged and Elderly Product Portfolio Table 134. Biosearch Life Recent Development Table 135. UAS Laboratories Company Information Table 136. UAS Laboratories Business Overview Table 137. UAS Laboratories Probiotics for Middle-aged and Elderly Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. UAS Laboratories Probiotics for Middle-aged and Elderly Product Portfolio Table 139. UAS Laboratories Recent Development Table 140. Synbiotech Company Information Table 141. Synbiotech Business Overview Table 142. Synbiotech Probiotics for Middle-aged and Elderly Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. Synbiotech Probiotics for Middle-aged and Elderly Product Portfolio Table 144. Synbiotech Recent Development Table 145. Key Raw Materials Table 146. Raw Materials Key Suppliers Table 147. Probiotics for Middle-aged and Elderly Distributors List Table 148. Probiotics for Middle-aged and Elderly Customers List Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. Probiotics for Middle-aged and Elderly Product Image Figure 2. Global Probiotics for Middle-aged and Elderly Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Probiotics for Middle-aged and Elderly Sales Value (2021-2032) & (US$ Million) Figure 4. Global Probiotics for Middle-aged and Elderly Sales (2021-2032) & (k units) Figure 5. Global Probiotics for Middle-aged and Elderly Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Probiotics for Middle-aged and Elderly Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Lactic Acid Bacteria Image Figure 10. Bifidobacterium Image Figure 11. Others Image Figure 12. Global Probiotics for Middle-aged and Elderly Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Probiotics for Middle-aged and Elderly Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Probiotics for Middle-aged and Elderly Sales Volume Share by Type (2021-2032) Figure 15. Global Probiotics for Middle-aged and Elderly Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Probiotics for Middle-aged and Elderly Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Probiotics for Middle-aged and Elderly Sales Value Share by Type (2021-2032) Figure 18. Supermarket Image Figure 19. Online Retail Image Figure 20. Others Image Figure 21. Global Probiotics for Middle-aged and Elderly Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Probiotics for Middle-aged and Elderly Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Probiotics for Middle-aged and Elderly Sales Volume Share by Application (2021-2032) Figure 24. Global Probiotics for Middle-aged and Elderly Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Probiotics for Middle-aged and Elderly Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Probiotics for Middle-aged and Elderly Sales Value Share by Application (2021-2032) Figure 27. Global Probiotics for Middle-aged and Elderly Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Probiotics for Middle-aged and Elderly Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Probiotics for Middle-aged and Elderly Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Probiotics for Middle-aged and Elderly Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Probiotics for Middle-aged and Elderly Sales Value (2021-2032) & (US$ Million) Figure 32. North America Probiotics for Middle-aged and Elderly Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Probiotics for Middle-aged and Elderly Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Probiotics for Middle-aged and Elderly Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Probiotics for Middle-aged and Elderly Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Probiotics for Middle-aged and Elderly Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Probiotics for Middle-aged and Elderly Sales Value (2021-2032) & (US$ Million) Figure 38. South America Probiotics for Middle-aged and Elderly Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Probiotics for Middle-aged and Elderly Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Probiotics for Middle-aged and Elderly Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Probiotics for Middle-aged and Elderly Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Probiotics for Middle-aged and Elderly Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Lactic Acid Bacteria
  • Bifidobacterium
  • Others
Applications
  • Supermarket
  • Online Retail
  • Others
Companies covered
  • DuPont(Danisco)
  • Chr. Hansen
  • China-Biotics
  • Nestle
  • Danone
  • BioGaia
  • OMNi-BiOTiC
  • Glory Biotech
  • Ganeden
  • Morinaga Milk Industry
  • Sabinsa
  • Greentech
  • Bioriginal
  • Biosearch Life
  • UAS Laboratories
  • Synbiotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Probiotics for Middle-aged and Elderly Sales Value (2021-2032)
  4. 1.2.2 Global Probiotics for Middle-aged and Elderly Sales Volume (2021-2032)
  5. 1.2.3 Global Probiotics for Middle-aged and Elderly Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Probiotics for Middle-aged and Elderly Market Dynamics
  1. 2.1 Probiotics for Middle-aged and Elderly Industry Trends
  2. 2.2 Probiotics for Middle-aged and Elderly Industry Drivers
  3. 2.3 Probiotics for Middle-aged and Elderly Industry Opportunities and Challenges
  4. 2.4 Probiotics for Middle-aged and Elderly Industry Restraints
3 Probiotics for Middle-aged and Elderly Market by Company
  1. 3.1 Global Probiotics for Middle-aged and Elderly Company Revenue Ranking in 2025
  2. 3.2 Global Probiotics for Middle-aged and Elderly Revenue by Company (2021-2026)
  3. 3.3 Global Probiotics for Middle-aged and Elderly Sales Volume by Company (2021-2026)
  4. 3.4 Global Probiotics for Middle-aged and Elderly Average Price by Company (2021-2026)
  5. 3.5 Global Probiotics for Middle-aged and Elderly Company Ranking (2024-2026)
  6. 3.6 Global Probiotics for Middle-aged and Elderly Company Manufacturing Base and Headquarters
  7. 3.7 Global Probiotics for Middle-aged and Elderly Company Product Type and Application
  8. 3.8 Global Probiotics for Middle-aged and Elderly Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Probiotics for Middle-aged and Elderly Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Probiotics for Middle-aged and Elderly Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Probiotics for Middle-aged and Elderly Market by Type
  1. 4.1 Probiotics for Middle-aged and Elderly Type Introduction
  2. 4.1.1 Lactic Acid Bacteria
  3. 4.1.2 Bifidobacterium
  4. 4.1.3 Others
  5. 4.2 Global Probiotics for Middle-aged and Elderly Sales Volume by Type
  6. 4.2.1 Global Probiotics for Middle-aged and Elderly Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Probiotics for Middle-aged and Elderly Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Probiotics for Middle-aged and Elderly Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Probiotics for Middle-aged and Elderly Sales Value by Type
  10. 4.3.1 Global Probiotics for Middle-aged and Elderly Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Probiotics for Middle-aged and Elderly Sales Value by Type (2021-2032)
  12. 4.3.3 Global Probiotics for Middle-aged and Elderly Sales Value Share by Type (2021-2032)
5 Probiotics for Middle-aged and Elderly Market by Application
  1. 5.1 Probiotics for Middle-aged and Elderly Application Introduction
  2. 5.1.1 Supermarket
  3. 5.1.2 Online Retail
  4. 5.1.3 Others
  5. 5.2 Global Probiotics for Middle-aged and Elderly Sales Volume by Application
  6. 5.2.1 Global Probiotics for Middle-aged and Elderly Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Probiotics for Middle-aged and Elderly Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Probiotics for Middle-aged and Elderly Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Probiotics for Middle-aged and Elderly Sales Value by Application
  10. 5.3.1 Global Probiotics for Middle-aged and Elderly Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Probiotics for Middle-aged and Elderly Sales Value by Application (2021-2032)
  12. 5.3.3 Global Probiotics for Middle-aged and Elderly Sales Value Share by Application (2021-2032)
6 Probiotics for Middle-aged and Elderly Regional Sales and Value Analysis
  1. 6.1 Global Probiotics for Middle-aged and Elderly Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Probiotics for Middle-aged and Elderly Sales by Region (2021-2032)
  3. 6.2.1 Global Probiotics for Middle-aged and Elderly Sales by Region: 2021-2026
  4. 6.2.2 Global Probiotics for Middle-aged and Elderly Sales by Region (2027-2032)
  5. 6.3 Global Probiotics for Middle-aged and Elderly Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Probiotics for Middle-aged and Elderly Sales Value by Region (2021-2032)
  7. 6.4.1 Global Probiotics for Middle-aged and Elderly Sales Value by Region: 2021-2026
  8. 6.4.2 Global Probiotics for Middle-aged and Elderly Sales Value by Region (2027-2032)
  9. 6.5 Global Probiotics for Middle-aged and Elderly Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Probiotics for Middle-aged and Elderly Sales Value (2021-2032)
  12. 6.6.2 North America Probiotics for Middle-aged and Elderly Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Probiotics for Middle-aged and Elderly Sales Value (2021-2032)
  15. 6.7.2 Europe Probiotics for Middle-aged and Elderly Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Probiotics for Middle-aged and Elderly Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Probiotics for Middle-aged and Elderly Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Probiotics for Middle-aged and Elderly Sales Value (2021-2032)
  21. 6.9.2 South America Probiotics for Middle-aged and Elderly Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Probiotics for Middle-aged and Elderly Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Probiotics for Middle-aged and Elderly Sales Value Share by Country, 2025 VS 2032
7 Probiotics for Middle-aged and Elderly Country-level Sales and Value Analysis
  1. 7.1 Global Probiotics for Middle-aged and Elderly Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Probiotics for Middle-aged and Elderly Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Probiotics for Middle-aged and Elderly Sales by Country (2021-2032)
  4. 7.3.1 Global Probiotics for Middle-aged and Elderly Sales by Country (2021-2026)
  5. 7.3.2 Global Probiotics for Middle-aged and Elderly Sales by Country (2027-2032)
  6. 7.4 Global Probiotics for Middle-aged and Elderly Sales Value by Country (2021-2032)
  7. 7.4.1 Global Probiotics for Middle-aged and Elderly Sales Value by Country (2021-2026)
  8. 7.4.2 Global Probiotics for Middle-aged and Elderly Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Probiotics for Middle-aged and Elderly Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Probiotics for Middle-aged and Elderly Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Probiotics for Middle-aged and Elderly Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 DuPont(Danisco)
  2. 8.1.1 DuPont(Danisco) Company Information
  3. 8.1.2 DuPont(Danisco) Business Overview
  4. 8.1.3 DuPont(Danisco) Probiotics for Middle-aged and Elderly Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 DuPont(Danisco) Probiotics for Middle-aged and Elderly Product Portfolio
  6. 8.1.5 DuPont(Danisco) Recent Developments
  7. 8.2 Chr. Hansen
  8. 8.2.1 Chr. Hansen Company Information
  9. 8.2.2 Chr. Hansen Business Overview
  10. 8.2.3 Chr. Hansen Probiotics for Middle-aged and Elderly Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Chr. Hansen Probiotics for Middle-aged and Elderly Product Portfolio
  12. 8.2.5 Chr. Hansen Recent Developments
  13. 8.3 China-Biotics
  14. 8.3.1 China-Biotics Company Information
  15. 8.3.2 China-Biotics Business Overview
  16. 8.3.3 China-Biotics Probiotics for Middle-aged and Elderly Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 China-Biotics Probiotics for Middle-aged and Elderly Product Portfolio
  18. 8.3.5 China-Biotics Recent Developments
  19. 8.4 Nestle
  20. 8.4.1 Nestle Company Information
  21. 8.4.2 Nestle Business Overview
  22. 8.4.3 Nestle Probiotics for Middle-aged and Elderly Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Nestle Probiotics for Middle-aged and Elderly Product Portfolio
  24. 8.4.5 Nestle Recent Developments
  25. 8.5 Danone
  26. 8.5.1 Danone Company Information
  27. 8.5.2 Danone Business Overview
  28. 8.5.3 Danone Probiotics for Middle-aged and Elderly Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Danone Probiotics for Middle-aged and Elderly Product Portfolio
  30. 8.5.5 Danone Recent Developments
  31. 8.6 BioGaia
  32. 8.6.1 BioGaia Company Information
  33. 8.6.2 BioGaia Business Overview
  34. 8.6.3 BioGaia Probiotics for Middle-aged and Elderly Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 BioGaia Probiotics for Middle-aged and Elderly Product Portfolio
  36. 8.6.5 BioGaia Recent Developments
  37. 8.7 OMNi-BiOTiC
  38. 8.7.1 OMNi-BiOTiC Company Information
  39. 8.7.2 OMNi-BiOTiC Business Overview
  40. 8.7.3 OMNi-BiOTiC Probiotics for Middle-aged and Elderly Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 OMNi-BiOTiC Probiotics for Middle-aged and Elderly Product Portfolio
  42. 8.7.5 OMNi-BiOTiC Recent Developments
  43. 8.8 Glory Biotech
  44. 8.8.1 Glory Biotech Company Information
  45. 8.8.2 Glory Biotech Business Overview
  46. 8.8.3 Glory Biotech Probiotics for Middle-aged and Elderly Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Glory Biotech Probiotics for Middle-aged and Elderly Product Portfolio
  48. 8.8.5 Glory Biotech Recent Developments
  49. 8.9 Ganeden
  50. 8.9.1 Ganeden Company Information
  51. 8.9.2 Ganeden Business Overview
  52. 8.9.3 Ganeden Probiotics for Middle-aged and Elderly Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Ganeden Probiotics for Middle-aged and Elderly Product Portfolio
  54. 8.9.5 Ganeden Recent Developments
  55. 8.10 Morinaga Milk Industry
  56. 8.10.1 Morinaga Milk Industry Company Information
  57. 8.10.2 Morinaga Milk Industry Business Overview
  58. 8.10.3 Morinaga Milk Industry Probiotics for Middle-aged and Elderly Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Morinaga Milk Industry Probiotics for Middle-aged and Elderly Product Portfolio
  60. 8.10.5 Morinaga Milk Industry Recent Developments
  61. 8.11 Sabinsa
  62. 8.11.1 Sabinsa Company Information
  63. 8.11.2 Sabinsa Business Overview
  64. 8.11.3 Sabinsa Probiotics for Middle-aged and Elderly Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sabinsa Probiotics for Middle-aged and Elderly Product Portfolio
  66. 8.11.5 Sabinsa Recent Developments
  67. 8.12 Greentech
  68. 8.12.1 Greentech Company Information
  69. 8.12.2 Greentech Business Overview
  70. 8.12.3 Greentech Probiotics for Middle-aged and Elderly Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Greentech Probiotics for Middle-aged and Elderly Product Portfolio
  72. 8.12.5 Greentech Recent Developments
  73. 8.13 Bioriginal
  74. 8.13.1 Bioriginal Company Information
  75. 8.13.2 Bioriginal Business Overview
  76. 8.13.3 Bioriginal Probiotics for Middle-aged and Elderly Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Bioriginal Probiotics for Middle-aged and Elderly Product Portfolio
  78. 8.13.5 Bioriginal Recent Developments
  79. 8.14 Biosearch Life
  80. 8.14.1 Biosearch Life Company Information
  81. 8.14.2 Biosearch Life Business Overview
  82. 8.14.3 Biosearch Life Probiotics for Middle-aged and Elderly Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Biosearch Life Probiotics for Middle-aged and Elderly Product Portfolio
  84. 8.14.5 Biosearch Life Recent Developments
  85. 8.15 UAS Laboratories
  86. 8.15.1 UAS Laboratories Company Information
  87. 8.15.2 UAS Laboratories Business Overview
  88. 8.15.3 UAS Laboratories Probiotics for Middle-aged and Elderly Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 UAS Laboratories Probiotics for Middle-aged and Elderly Product Portfolio
  90. 8.15.5 UAS Laboratories Recent Developments
  91. 8.16 Synbiotech
  92. 8.16.1 Synbiotech Company Information
  93. 8.16.2 Synbiotech Business Overview
  94. 8.16.3 Synbiotech Probiotics for Middle-aged and Elderly Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Synbiotech Probiotics for Middle-aged and Elderly Product Portfolio
  96. 8.16.5 Synbiotech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Probiotics for Middle-aged and Elderly Value Chain Analysis
  2. 9.1.1 Probiotics for Middle-aged and Elderly Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Probiotics for Middle-aged and Elderly Sales Mode & Process
  6. 9.2 Probiotics for Middle-aged and Elderly Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Probiotics for Middle-aged and Elderly Distributors
  9. 9.2.3 Probiotics for Middle-aged and Elderly Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst